AtaiBeckley Inc. (NASDAQ: ATAI) has completed the redomiciliation of its parent company from the Netherlands to a U.S. entity in Delaware. This move was approved by 99% of shareholders and will save costs, align with the U.S. listing, and simplify corporate structure. All issued shares of Atai Beckley N.V. were exchanged for shares of AtaiBeckley Inc. The company’s common stock will still trade on NASDAQ under “ATAI”. AtaiBeckley is focused on developing mental health treatments like BPL-003 for treatment-resistant depression and VLS-01 for social anxiety disorder. They aim to provide effective and convenient therapies for mental health issues.

Read more at GlobeNewswire: AtaiBeckley Completes Redomiciliation to the United States